MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, will launch the NovaSure® V5 global endometrial ablation (GEA) device at the American Association ...
“Since its launch over 20 years ago, we have constantly listened to our customers’ feedback, which has driven continuous design improvements for NovaSure,” said Jan Verstreken, Group President, ...
London, ON, October 1, 2024 – A new study has found that 29 per cent of people in Ontario who undergo endometrial ablation will have a subsequent hysterectomy to remove the entire uterus within 15 ...
Please provide your email address to receive an email when new articles are posted on . Reintervention rates were higher for hysteroscopic myomectomy, uterine artery embolization and endometrial ...
BERKELEY, Calif.--(BUSINESS WIRE)--Channel Medsystems, Inc., a medical device company whose mission is to empower every woman to take control of her health journey, today announced that the first ...
Please provide your email address to receive an email when new articles are posted on . Live birth rates were similar for women with uterine fibroids who underwent radiofrequency ablation or ...
In this "in-between-isode" of our podcast Anamnesis, MedPage Today's Editor-in-Chief Marty Makary, MD, MPH, interviews Ali Ghomi, MD, a gynecologic surgeon in Buffalo, New York. Ghomi says a quarter ...
Benign tissue formations in the muscle tissue of the uterine wall (fibroids), polyps or endometriosis may cause excessively heavy and prolonged menstrual bleeding (menorrhagia). However, the reason ...
The charge that too many women have hysterectomies was first leveled at the medical profession 50 years ago. It appears little has changed. A new report from the federal government shows that the ...
Uterine fibroids (also known as uterine leiomyomas or myomas) are benign tumours of the uterus. They can be asymptomatic or cause symptoms including heavy periods or bleeding between periods. They can ...
Over the last 20 years, the NovaSure system has built a trusted legacy in GEA. The NovaSure device first received FDA approval in 2001, and by 2018 the NovaSure procedure had been used to treat over 3 ...